From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 18,227,779 shares, representing 25.26% for $588.23 million under the buyback announced on November 5, 2013.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.54 USD | -0.32% | +3.15% | +28.27% |
01:54pm | Scotiabank Initiates Myriad Genetics at Sector Outperform | MT |
12/06 | Transcript : Myriad Genetics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 03:20 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.27% | 222.83Cr | |
-10.34% | 1.16TCr | |
-12.48% | 737.49Cr | |
+29.63% | 544.24Cr | |
+0.26% | 530.74Cr | |
-18.68% | 374.07Cr | |
+7.43% | 257.81Cr | |
-64.58% | 233.43Cr | |
-11.15% | 220.67Cr | |
-16.74% | 166.58Cr |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Tranche Update on Myriad Genetics, Inc.'s Equity Buyback Plan announced on November 5, 2013.